Dead-Sea climatotherapy versus other modalities of treatment for psoriasis: comparative cost-effectiveness

被引:27
|
作者
Shani, J
Harari, M [1 ]
Hristakieva, E
Seidl, V
Bar-Giyora, J
机构
[1] Deutsch Med Zentrum Clin, Lot Hotel, MOR, IL-86930 Ein Bokek, Israel
[2] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, Jerusalem, Israel
关键词
D O I
10.1046/j.1365-4362.1999.00583.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:252 / 262
页数:11
相关论文
共 50 条
  • [31] Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective
    Jinsui Zhang
    Zemin Xia
    Wanjie Guo
    Xiaoxiao Ren
    Fang Liu
    Gargi Ratnaparkhi
    Amit Pagada
    Subhashini Subramanian
    Min Hu
    Wen Chen
    Dermatology and Therapy, 2023, 13 : 2681 - 2696
  • [32] Comparative Cost-Effectiveness of Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndromes (MDS)
    Miller, Jeffrey D.
    Fenaux, Pierre
    Beach, C. L.
    Gidwani, Risha
    Khan, Zeba M.
    BLOOD, 2009, 114 (22) : 561 - 561
  • [33] The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies
    Pearce, DJ
    Nelson, AA
    Fleischer, AB
    Balkrishnan, R
    Feldman, SR
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2006, 17 (01) : 29 - 37
  • [34] COMPARATIVE EFFECTIVENESS OF LASER ATHERECTOMY VERSUS OTHER TREATMENT MODALITIES FOR PATIENTS WITH IN-STENT RESTENOSIS
    Ganesh, Rajan
    Shah, Amit
    Biondi, Max
    Amin, Amit P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1081 - 1081
  • [35] Climatotherapy at the Dead Sea for psoriasis is a highly effective anti-inflammatory treatment in the short term: An immunohistochemical study
    Emmanuel, Thomas
    Petersen, Annita
    Houborg, Hannah Inez
    Ronsholdt, Anders Benjamin
    Lybaek, Dorte
    Steiniche, Torben
    Bregnhoj, Anne
    Iversen, Lars
    Johansen, Claus
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (08) : 1136 - 1144
  • [36] COST-EFFECTIVENESS OF SECUKINUMAB VERSUS OTHER BIOLOGICS IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: A SPANISH PERSPECTIVE
    Monteagudo, I
    Navarro-Ruiz, A.
    Khare, A.
    Gunda, P.
    Blanch, C.
    VALUE IN HEALTH, 2019, 22 : S421 - S421
  • [37] COST-EFFECTIVENESS OF SECUKINUMAB VERSUS OTHER BIOLOGICS IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: AN ARGENTINEAN PERSPECTIVE
    Citera, Gustavo
    Bianculli, Pablo Manuel
    Khare, Ankur
    Jain, Minal
    Aiello, Eleonora
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S117 - S117
  • [38] Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective
    Aiello, Eleonora
    Manuel Bianculli, Pablo
    Bhattacharyya, Devarshi
    Gunda, Praveen
    Citera, Gustavo
    VALUE IN HEALTH REGIONAL ISSUES, 2019, 20 : 86 - 94
  • [39] COST-EFFECTIVENESS OF APREMILAST FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A803 - A803
  • [40] COST-EFFECTIVENESS COMPARISON OF RISANKIZUMAB AND USTEKINUMAB FOR THE TREATMENT OF SEVERE PSORIASIS
    Dzik, M.
    Nadzieja-Koziol, A.
    Owczarek, W.
    VALUE IN HEALTH, 2019, 22 : S423 - S423